I-Mab Soared

I-Mab (IMAB:NASDAQ) soared at $1.87, representing a gain of 46.1%. On Tue, Jun 03, 2025, IMAB:NASDAQ hit a New 2-Week High of $1.87. The stock got featured on our News Catalysts scanner on Tue, Jun 03, 2025 at 10:34 AM in the 'MISCELLANEOUS' category. From Tue, May 20, 2025, the stock recorded 77.78% Up Days and 50.00% Green Days

About I-Mab (IMAB:NASDAQ)

I-MAB is a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel or highly differentiated biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders. The company's product pipeline includes TJ202, TJ301, TJ107, TJC4, TJD5, and TJM2.